UBS Group’s Achieve Life Sciences QUIT Stock Holding History
Bought
Maintained
Sold
Other funds holding QUIT
UBS Group's QUIT Position: Q3 2026 in Review
UBS Group reduced its Achieve Life Sciences (QUIT) stake by 6.5% in Q3 2026, selling an estimated $146K and leaving 292,583 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #4863.
UBS Group first reported a position in QUIT in Q4 2014 and has held it in 38 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.
- UBS Group held 292,583 shares of Achieve Life Sciences worth $2.37M as of Q3 2026.
- UBS Group sold 20,421 Achieve Life Sciences shares in Q3 2026, an estimated $146K.
- Achieve Life Sciences made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4863 holding.
- UBS Group first reported a position in Achieve Life Sciences in Q4 2014 and has held it in 38 quarters since.
- 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.